Serveur d'exploration sur le lymphœdème - Exploration (Accueil)

Index « KwdFr.i » - entrée « Diéthylcarbamazine (effets indésirables) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Diéthylcarbamazine (analyse) < Diéthylcarbamazine (effets indésirables) < Diéthylcarbamazine (normes)  Facettes :

List of bibliographic references indexed by Diéthylcarbamazine (effets indésirables)

Number of relevant bibliographic references: 59.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
001123 (2016) Edward K. Thomsen [Papouasie-Nouvelle-Guinée] ; Nelly Sanuku [Papouasie-Nouvelle-Guinée] ; Manasseh Baea [Papouasie-Nouvelle-Guinée] ; Samson Satofan [Papouasie-Nouvelle-Guinée] ; Elit Maki [Papouasie-Nouvelle-Guinée] ; Bart Lombore [Papouasie-Nouvelle-Guinée] ; Mark S. Schmidt [États-Unis] ; Peter M. Siba [Papouasie-Nouvelle-Guinée] ; Gary J. Weil [États-Unis] ; James W. Kazura [États-Unis] ; Lawrence L. Fleckenstein [États-Unis] ; Christopher L. King [États-Unis]Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
002099 (2015) Ram Kumar Adhikari [Oman] ; Jeevan Bahadur Sherchand ; Shiva Raj Mishra ; Kamal Ranabhat ; Rajendra Raj WagleAwareness and coverage of mass drug administration for elimination of lymphatic filariasis: a community based cross sectional study in Nepal.
004524 (2012) Ana Wládia Lima [Brésil] ; Zulma Medeiros ; Zailde Carvalho Dos Santos ; Gertrudes Monteiro Da Costa ; Cynthia BragaAdverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil.
004E41 (2011) Chandrakant Lahariya [Inde] ; Shailendra S. TomarHow endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.
005640 (2010) R. Rajendran [Inde] ; I P Sunish ; A. Munirathinam ; V. Ashok Kumar ; B K TyagiRole of community empowerment in the elimination of lymphatic filariasis in south India.
005A50 (2010) Vivornpun Sanprasert [Thaïlande] ; Anupong Sujariyakul ; Surang NuchprayoonA single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis.
006929 (2008) Chandrakant Lahariya [Inde] ; Ashok MishraStrengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
006991 (2008) Sharmini Gunawardena [Sri Lanka] ; Shalini Sri Ranganathan ; Rohini FernandopullePharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
006A44 (2008) Lymphatic filariasis.
006B46 (2008) Taniawati Supali [Indonésie] ; Yenny Djuardi ; Kenneth M. Pfarr ; Heri Wibowo ; Mark J. Taylor ; Achim Hoerauf ; Jeanine J. Houwing-Duistermaat ; M. Yazdanbakhsh ; Erliyani SartonoDoxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment.
007279 (2007) Caroline A. Grady [États-Unis] ; Madsen Beau De Rochars [Haïti] ; Abdel N. Direny [Haïti] ; Jean Nicolas Orelus [Haïti] ; Joyanna Wendt [États-Unis] ; Jeanne Radday [États-Unis] ; Els Mathieu [États-Unis] ; Jacquelin M. Roberts [États-Unis] ; Thomas G. Streit [États-Unis] ; David G. Addiss [États-Unis] ; Patrick J. Lammie [États-Unis]Endpoints for Lymphatic Filariasis Programs
007321 (2007) J A Rizzo [Brésil] ; C. Belo ; R. Lins ; G. DreyerChildren and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole.
007803 (2006) Alison Krentel [Indonésie] ; Peter Fischer ; Paul Manoempil ; Taniawati Supali ; Gérard Servais ; Paul RückertUsing knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
007914 (2006) K. Regu ; M K Showkath Ali ; R. Rajendran ; S M Koya ; B. Ganesh ; A C Dhariwal ; Shiv LalMass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala State.
007953 (2006) W H Makunde [Tanzanie] ; M L Kamugisha ; R A Makunde ; M N Malecela-Lazaro ; A Y KituaImplication of diethylcarbamazine induced morbidity and the role of cellular responses associated with bancroftian filariasis pathologies.
007A47 (2006) B V Babu [Inde] ; K. Rath ; A S Kerketta ; B K Swain ; S. Mishra ; S K KarAdverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
007E47 (2005) S P Pani ; L K Das ; P. VanamailTolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF).
007F09 (2005) Kapa D. Ramaiah ; Rengachari Ravi ; Pradeep K. DasPreventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
007F20 (2005) P. Vanamail [Inde] ; K D Ramaiah ; S. Subramanian ; S P Pani ; J. Yuvaraj ; P K DasPattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
008693 (2004) S P Pani ; G Subramanyam Reddy ; P. Vanamail ; N. Venkatesvarlou ; L K Das ; A P VijayanTolerability and efficacy of single dose diethylcarbamazine (DEC) alone or co-administration with Ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India.
008834 (2004) B V Babu [Inde] ; S K KarCoverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Diéthylcarbamazine (effets indésirables)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Diéthylcarbamazine (effets indésirables)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Diéthylcarbamazine (effets indésirables)
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024